Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 3
2017 2
2018 2
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Curcumin and Melanoma: From Chemistry to Medicine.
Nabavi SM, Russo GL, Tedesco I, Daglia M, Orhan IE, Nabavi SF, Bishayee A, Nagulapalli Venkata KC, Abdollahi M, Hajheydari Z. Nabavi SM, et al. Among authors: Nagulapalli Venkata KC. Nutr Cancer. 2018 Feb-Mar;70(2):164-175. doi: 10.1080/01635581.2018.1412485. Epub 2018 Jan 4. Nutr Cancer. 2018. PMID: 29300102 Review.
The analgesic potential of glycosides derived from medicinal plants.
Khan H, Pervaiz A, Intagliata S, Das N, Nagulapalli Venkata KC, Atanasov AG, Najda A, Nabavi SM, Wang D, PittalĂ  V, Bishayee A. Khan H, et al. Among authors: Nagulapalli Venkata KC. Daru. 2020 Jun;28(1):387-401. doi: 10.1007/s40199-019-00319-7. Epub 2020 Feb 14. Daru. 2020. PMID: 32060737 Free article. Review.
Molecular Targets Underlying the Anticancer Effects of Quercetin: An Update.
Khan F, Niaz K, Maqbool F, Ismail Hassan F, Abdollahi M, Nagulapalli Venkata KC, Nabavi SM, Bishayee A. Khan F, et al. Among authors: Nagulapalli Venkata KC. Nutrients. 2016 Aug 29;8(9):529. doi: 10.3390/nu8090529. Nutrients. 2016. PMID: 27589790 Free PMC article. Review.
The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models.
Ning Y, Labonte MJ, Zhang W, Bohanes PO, Gerger A, Yang D, Benhaim L, Paez D, Rosenberg DO, Nagulapalli Venkata KC, Louie SG, Petasis NA, Ladner RD, Lenz HJ. Ning Y, et al. Among authors: Nagulapalli Venkata KC. Mol Cancer Ther. 2012 Jun;11(6):1353-64. doi: 10.1158/1535-7163.MCT-11-0915. Epub 2012 Mar 5. Mol Cancer Ther. 2012. PMID: 22391039 Free article.
Feedback